UPDATE 1-Pharma execs weigh in on possible changes under Trump
December 01, 2016 at 15:56 PM EST
Dec 1 (Reuters) - The top executives at two of the largest U.S. drugmakers weighed in on Thursday for the first time on possible changes for the industry next year under U.S. President-elect Donald Trump.
